DexCom Inc at Raymond James Institutional Investors Conference Transcript
Okay. Super. Welcome to the 40th Annual Raymond James Institutional Investors Conference. My name is Jayson Bedford. I'm the medical device analyst here. Thank you for joining us and choosing this presentation over the sunshine outside. It's really our pleasure to have with us the senior management team from DexCom, who've been coming to this conference for many years.
So with us, we have the EVP of Strategy and Corporate Development, Steve Pacelli; as well as Sean Christensen, Head of Investor Relations. So with that, I'm going to pass it on to Steve.
Great. Thank you, Jayson, and thank you all for joining us here this afternoon. So as far as the format, what I thought I would do is I'm going to start with a few highlights from 2018 and a quick review of our guidance for 2019. Then I'm going to take you through kind of a high-level overview of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |